Pharmode

Pharmode is a South Korean biotechnology company specializing in the development of advanced drug delivery systems, with a primary focus on dissolving microneedle (DMN) technology. The company's platform is designed to provide a minimally invasive, painless alternative to traditional injections, enhancing patient compliance and drug stability. Pharmode's pipeline includes microneedle-based formulations for high-demand indications such as obesity, metabolic diseases, and osteoporosis. By leveraging its proprietary manufacturing processes, the company aims to deliver both small molecules and complex biologics, including GLP-1 receptor agonists and vaccines, through convenient transdermal patches.